Orodispersible Tablets Market

Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Purview
   • Report Description 
     • Market Definition and Scope
   • Executive Summary
     • Market Orodispersible Tablets, By Drug Class
     • Market Orodispersible Tablets, By Disease Indication
     • Market Orodispersible Tablets, By Age Group
     • Market Orodispersible Tablets, By Distribution Channel
     • Market Orodispersible Tablets, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Drivers
     • Market Dynamics
       • Increasing Prevalence of Chronic Diseases
       • Technological Advancements in Drug Delivery
       • Enhanced Patient Compliance and Convenience
       • Growing Focus on Patient-Centered Care
     • Restraints
       • High Development and Manufacturing Costs
       • Limited Drug Compatibility and Formulation Options
     • Opportunities
       • Increasing Demand for Personalized Medicine
       • Rising Adoption of Digital Health Solutions
       • Development of Innovative Taste-Masking Techniques
       • Focus on Fast-Dissolving Formulations
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Merger and Acquisition Scenario
4. Global Orodispersible Tablets Market– Impact of Coronavirus (COVID-19) Pandemic
   • COVID-19 Epidemiology
   • Supply Side and Demand Side Analysis
   • Economic Impact
5. Global Orodispersible Tablets Market, By Drug Class, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019 – 2030
     • Segment Trends
   • Analgesics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   •  Antiemetics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Antipsychotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Anti-inflammatory Drugs
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Sedatives/Hypnotics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Antihypertensives
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
6. Global Orodispersible Tablets Market, By Disease Indication, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019– 2030
     • Segment Trends
   • Pain Management
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Allergy and Respiratory Disorders
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Neurological Disorders
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Gastrointestinal Disorders
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Cardiovascular Disorders
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Others
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
7. Global Orodispersible Tablets Market, By Age Group, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023and 2030 (%)
     • Y-o-Y Growth Analysis, 2023– 2030
     • Segment Trends
   • Pediatric Patients
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Adult Patients
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Geriatric Patients
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
8. Global Orodispersible Tablets Market, By Distribution Channel, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, 2019– 2030
     • Segment Trends
   • Hospital Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Retail Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
   • Online Pharmacies
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
9. Global Orodispersible Tablets Market, By Region, 2018-2030, (US$ Bn)
   • Introduction
     • Market Share Analysis, By Region, 2023 and 2030 (%)
     • Y-o-Y Growth Analysis, For Region, 2019–2030
     • Country Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • U.S.
       • Canada
   • Europe
     
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Middle East & Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
       • GCC
       • Israel
       • North Africa
       • Central Africa
       • Rest of Middle East & Africa
10. Competitive Landscape
    • AstraZeneca PLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • GlaxoSmithKline PLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis International AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Johnson & Johnson Services, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Cipla Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Reddy's Laboratories Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Lupin Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Torrent Pharmaceuticals Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eisai Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
11. Section
    • Research Methodology
    • About us

*Browse 24 market data tables and 28 figures on "Global Orodispersible Tablets Market” - Global forecast to 2030